SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-16-003555
Filing Date
2016-05-18
Accepted
2016-05-18 15:28:59
Documents
20
Period of Report
2016-05-18

Document Format Files

Seq Description Document Type Size
1 6-K v440291_6k.htm 6-K 5613
2 EXHIBIT 99.1 v440291_ex99-1.htm EX-99.1 459167
3 GRAPHIC image_001.jpg GRAPHIC 17526
4 GRAPHIC image_002.jpg GRAPHIC 30588
5 GRAPHIC image_003.jpg GRAPHIC 9331
6 GRAPHIC image_004.jpg GRAPHIC 194629
7 GRAPHIC image_005.jpg GRAPHIC 64567
8 GRAPHIC image_006.jpg GRAPHIC 57772
9 GRAPHIC image_007.jpg GRAPHIC 67270
10 GRAPHIC image_008.jpg GRAPHIC 38115
11 GRAPHIC image_009.jpg GRAPHIC 74365
12 GRAPHIC image_010.jpg GRAPHIC 170854
13 GRAPHIC image_011.jpg GRAPHIC 175196
14 GRAPHIC image_012.jpg GRAPHIC 190642
15 GRAPHIC image_013.jpg GRAPHIC 178386
16 GRAPHIC image_014.jpg GRAPHIC 166481
17 GRAPHIC image_015.jpg GRAPHIC 69857
18 GRAPHIC image_016.jpg GRAPHIC 84363
19 GRAPHIC image_017.jpg GRAPHIC 84058
20 GRAPHIC image_018.jpg GRAPHIC 74505
  Complete submission text file 0001279569-16-003555.txt   2843102
Mailing Address 100 WELLINGTON ST. WEST SUITE 2110 P.O. BOX 151 TORONTO A6 M5K 1H1
Business Address 100 WELLINGTON ST. WEST SUITE 2110 P.O. BOX 151 TORONTO A6 M5K 1H1 416 593-3701
Merus Labs International Inc. (Filer) CIK: 0001031516 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 6-K | Act: 34 | File No.: 000-30082 | Film No.: 161660384
SIC: 2834 Pharmaceutical Preparations